Skip to main content
Top

Cancer Causes & Control

Issue 8/2013

Content (14 Articles)

Original paper

Rural–urban differences in health behaviors and implications for health status among US cancer survivors

Kathryn E. Weaver, Nynikka Palmer, Lingyi Lu, L. Douglas Case, Ann M. Geiger

Original paper

Associations among family history of cancer, cancer screening and lifestyle behaviors: a population-based study

Georgiana Bostean, Catherine M. Crespi, William J. McCarthy

Original paper

Association between non-steroidal anti-inflammatory drug use and melanoma risk: a meta-analysis of 13 studies

Shan Li, Yanqiong Liu, Zhiyu Zeng, Qiliu Peng, Ruolin Li, Li Xie, Xue Qin, Jinmin Zhao

Original paper

Hormone replacement therapy and risk of meningioma in women: a meta-analysis

Zuo-Xu Fan, Jian Shen, Yao-Yao Wu, Hai Yu, Yu Zhu, Ren-Ya Zhan

Original paper

Coffee consumption and the risk of overall and fatal prostate cancer in the NIH-AARP Diet and Health Study

Claire Bosire, Meir J. Stampfer, Amy F. Subar, Kathryn M. Wilson, Yikyung Park, Rashmi Sinha

Open Access Original paper

Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database

Andrea Farioli, Francesco Saverio Violante, Stefano Mattioli, Stefania Curti, David Kriebel

Original paper

Prospective cohort study on television viewing time and incidence of lung cancer: findings from the Japan Collaborative Cohort Study

Shigekazu Ukawa, Akiko Tamakoshi, Kenji Wakai, Hiroyuki Noda, Masahiko Ando, Hiroyasu Iso

Original paper

Dietary intake of B vitamins and methionine and breast cancer risk

Julie K. Bassett, Laura Baglietto, Allison M. Hodge, Gianluca Severi, John L. Hopper, Dallas R. English, Graham G. Giles

Original paper

Synchronous and metachronous malignancies: analysis of the Minneapolis Veterans Affairs (VA) tumor registry

Steven Powell, Gobind Tarchand, Thomas Rector, Mark Klein

Original paper

Coffee and risk of prostate cancer incidence and mortality in the Cancer of the Prostate in Sweden Study

Kathryn M. Wilson, Katarina Bälter, Elisabeth Möller, Hans-Olov Adami, Ove Andrén, Swen-Olof Andersson, Henrik Grönberg, Lorelei A. Mucci

Original paper

Recommendations for a national agenda to substantially reduce cervical cancer

Jennifer S. Smith, Noel T. Brewer, Debbie Saslow, Kenneth Alexander, Mildred R. Chernofsky, Richard Crosby, Libby Derting, Leah Devlin, Charles J. Dunton, Jeffrey Engle, Maria Fernandez, Mona Fouad, Warner Huh, Walter Kinney, Jennifer Pierce, Elena Rios, Mitchel C. Rothholz, Judith C. Shlay, Rivienne Shedd-Steele, Sally W. Vernon, Joan Walker, Theresa Wynn, Gregory D. Zimet, Baretta R. Casey

Original paper

Serum folate and prostate-specific antigen in the United States

Yueh-Ying Han, Ji Young Song, Evelyn O. Talbott

Open Access Original paper

Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case–control study of contralateral breast cancer risk in the WECARE Study

Jennifer D. Brooks, Sharon N. Teraoka, Leslie Bernstein, Lene Mellemkjær, Kathleen E. Malone, Charles F. Lynch, Robert W. Haile, Patrick Concannon, Anne S. Reiner, David J. Duggan, Katherine Schiermeyer, Jonine L. Bernstein, Jane C. Figueiredo

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine